Can a person have von Willebrand disease (VWD) if their absolute antigen levels of von Willebrand factor (VWF) are normal?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Von Willebrand Disease with Normal VWF Antigen Levels

Yes, a person can have von Willebrand disease (VWD) even with normal absolute antigen levels of von Willebrand factor (VWF), particularly in Type 2 variants where the defect is qualitative rather than quantitative. 1

Types of VWD with Normal Antigen Levels

Type 2 VWD represents qualitative defects in VWF function that can occur despite normal antigen levels:

  • Type 2M: Characterized by decreased VWF ristocetin cofactor activity (VWF:RCo) but normal VWF antigen (VWF:Ag) levels. The VWF:RCo/VWF:Ag ratio is typically <0.5-0.7, indicating dysfunctional VWF despite normal quantity. 1, 2

  • Type 2N: Presents with normal VWF:RCo and VWF:Ag but reduced factor VIII binding capacity, resembling mild hemophilia A. 1

  • Type 2A and 2B: While these often have reduced VWF:Ag levels, they can sometimes present with VWF:Ag in the normal range (30-200 IU/dL) but significantly reduced VWF:RCo. 1

Diagnostic Approach

When VWD is suspected despite normal VWF antigen levels:

  1. Calculate VWF:RCo to VWF:Ag ratio

    • Ratio <0.5-0.7 suggests Type 2 VWD 1
    • This is a critical step that can identify functional defects despite normal antigen levels
  2. Evaluate multimer pattern

    • Type 2M/2U: May show relative decreases in large VWF multimers with less resolved triplet structure 2
    • Type 2A: Loss of high and intermediate molecular weight multimers 1
    • Type 2B: Loss of high molecular weight multimers 1
  3. Perform ristocetin-induced platelet aggregation (RIPA)

    • Type 2M: Often normal at low-dose ristocetin 1
    • Type 2B: Usually enhanced at low-dose ristocetin 1
  4. Consider genetic testing

    • Type 2M/2U: Caused by loss-of-function mutations in the A1 domain of VWF gene 2, 3
    • Specific mutations like F606I and I662F have been identified in Type 2M with normal multimer patterns 3

Clinical Implications

  • Patients with Type 2 VWD and normal antigen levels may still have significant bleeding symptoms 3
  • Treatment approach differs from Type 1 VWD:
    • DDAVP (desmopressin) may be less effective in Type 2M VWD despite increasing VWF:Ag levels 2
    • VWF-containing factor concentrates are often needed for Type 2 variants 1

Common Pitfalls

  • Relying solely on VWF:Ag levels: This will miss qualitative defects in VWF function
  • Single testing: VWF levels can vary; repeat testing up to 3 times may be necessary 1
  • Overlooking the VWF:RCo/VWF:Ag ratio: This ratio is crucial for identifying Type 2 VWD
  • Incomplete laboratory evaluation: A comprehensive panel including VWF:Ag, VWF:RCo, FVIII activity, and multimer analysis is necessary for proper classification 1, 4

Remember that VWD is a heterogeneous disorder, and proper diagnosis requires assessment of both quantity and function of VWF. Normal antigen levels do not exclude VWD, particularly the qualitative Type 2 variants.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.